Devalingam Mahalingam Selected Research

Devalingam Mahalingam Research Topics

Disease

45	Neoplasms (Cancer) 05/2024 - 03/2009
10	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 11/2013
8	Adenocarcinoma 01/2023 - 11/2008
7	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 04/2014
7	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 06/2015
4	Fatigue 10/2022 - 04/2014
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2024 - 12/2020
3	Anemia 05/2024 - 08/2014
3	Neutropenia 10/2022 - 06/2012
3	Carcinogenesis 01/2020 - 12/2011
3	Melanoma (Melanoma, Malignant) 11/2017 - 07/2014
3	Neoplasm Metastasis (Metastasis) 12/2015 - 10/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015 - 11/2008
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2010 - 04/2009
2	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 10/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2023 - 01/2023
2	Cholangiocarcinoma 01/2023 - 08/2022
2	Inflammation (Inflammations) 12/2020 - 04/2009
2	Disease Progression 01/2020 - 06/2019
2	Lymphoma (Lymphomas) 06/2019 - 12/2011
2	Nausea 06/2019 - 08/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 03/2009
2	Liver Diseases (Liver Disease) 01/2017 - 06/2015
2	Thrombocytopenia (Thrombopenia) 03/2016 - 06/2012
2	Circulating Neoplastic Cells 01/2016 - 09/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2024
1	Wounds and Injuries (Trauma) 12/2020
1	Mucositis 12/2019
1	Adrenocortical Carcinoma 12/2019
1	Colonic Neoplasms (Colon Cancer) 06/2019

Drug/Important Bio-Agent (IBA)

9	Gemcitabine FDA Link 10/2022 - 11/2008
7	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2014
5	AndrogensIBA 10/2023 - 11/2013
5	EnzymesIBA 10/2022 - 05/2010
5	Vorinostat FDA Link 10/2022 - 01/2010
5	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 06/2012
4	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 03/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 10/2009
3	Metformin (Glucophage)FDA LinkGeneric 10/2023 - 10/2016
3	LigandsIBA 10/2022 - 05/2009
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2022 - 08/2014
3	pevonedistatIBA 10/2022 - 05/2010
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2019 - 02/2016
3	AlbuminsIBA 06/2019 - 10/2014
3	TOR Serine-Threonine KinasesIBA 06/2011 - 04/2009
3	Imatinib Mesylate (Gleevec)FDA Link 08/2010 - 04/2009
2	Phosphotransferases (Kinase)IBA 05/2024 - 10/2022
2	pembrolizumabIBA 01/2023 - 01/2020
2	NivolumabIBA 10/2022 - 12/2019
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 10/2022 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2015
2	Death Domain ReceptorsIBA 10/2022 - 05/2009
2	Yttrium-90IBA 08/2022 - 06/2019
2	Serum AlbuminIBA 08/2022 - 01/2017
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2020 - 05/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2019
2	BilirubinIBA 06/2019 - 01/2017
2	CreatinineIBA 06/2019 - 08/2014
2	Peptide Hydrolases (Proteases)FDA Link 06/2019 - 09/2016
2	Docetaxel (Taxotere)FDA Link 01/2019 - 12/2014
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 03/2018
2	RG7356IBA 11/2016 - 06/2015
2	Monoclonal AntibodiesIBA 11/2016 - 06/2012
2	Cathepsin DIBA 09/2016 - 02/2011
2	Histone Deacetylase InhibitorsIBA 09/2016 - 08/2014
2	CytokinesIBA 09/2016 - 05/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 11/2013
2	Caspase 3 (Caspase-3)IBA 07/2015 - 03/2009
2	Bevacizumab (Avastin)FDA Link 07/2014 - 04/2014
2	Adenosine Triphosphate (ATP)IBA 02/2011 - 10/2010
2	nilotinib FDA Link 09/2009 - 04/2009
1	Thrombospondin 1IBA 01/2024
1	Glycogen Synthase (Synthase I)IBA 11/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	regorafenibIBA 10/2022
1	Transaminases (Aminotransferases)IBA 10/2022
1	IpilimumabIBA 10/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2022
1	Cytochrome P-450 CYP3AIBA 10/2022
1	Circulating Tumor DNAIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Vascular Endothelial Growth Factor CIBA 12/2020
1	insulin receptor-related receptor (IRR)IBA 12/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Macrophage Migration-Inhibitory FactorsIBA 01/2020
1	Mitotane (Lysodren)FDA Link 12/2019
1	Alanine Transaminase (SGPT)IBA 12/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2019
1	Sunitinib (Sutent)FDA Link 06/2019

Therapy/Procedure

25	Therapeutics 05/2024 - 11/2008
12	Drug Therapy (Chemotherapy) 11/2023 - 11/2008
5	Immunotherapy 07/2019 - 10/2017
5	Castration 11/2016 - 06/2013
1	Drug Tapering 05/2024
1	Neoadjuvant Therapy 01/2023
1	Operative Time 12/2020
1	Length of Stay 12/2020
1	Infusion Pumps (Infusion Pump) 12/2020
1	Precision Medicine 04/2020